Real-time enrollment status for this iga nephropathy clinical trial
Current Status
Active, Not Recruiting
Checked: June 1, 2026 at 11:25 PM UTC
| NCT Number | NCT04557462 |
| Recruiting Status | Active, Not Recruiting |
| Condition | IgA Nephropathy |
| Phase | Clinical Trial |
| Target Enrollment | 540 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | June 1, 2026 (23 hours ago) |
As of June 1, 2026: Clinical trial NCT04557462 is currently active_not_recruiting participants. This clinical trial study for iga nephropathy is not currently accepting new participants at 15 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04557462 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04557462 was last updated 23 hours ago (June 1, 2026). HelloStudys verifies this status automatically.